Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
Clinical trial NCT06433219 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06433219
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2026-06-14
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.